Skip to main content

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

PNT holding history

POINT Biopharma Global Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PNT overviewAll 13F holders of PNTFull Q2 2026 holdings

Shares (Q4 2023)
0
Sold out in Q4 2023
Value
$0
% of portfolio
0.0%
Quarters held
9
Since Q3 2021
Holdings of PNT by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20230$00.0%−128,244−100.0%Sold outHolders
Q3 2023128,244$855.4K<0.1%−75,466−37.0%ReducedHolders
Q2 2023203,710$1.85M<0.1%+50,094+32.6%AddedHolders
Q1 2023153,616$1.12M<0.1%+107,946+236.4%AddedHolders
Q4 202245,670$332.9K<0.1%+25,747+129.2%AddedHolders
Q3 202219,923$155.0K<0.1%−56,754−74.0%ReducedHolders
Q2 202276,677$521.0K<0.1%+61,942+420.4%AddedHolders
Q1 202214,735$117.0K<0.1%+8,830+149.5%AddedHolders
Q4 20215,905$33.0K<0.1%+2,420+69.4%AddedHolders
Q3 20213,485$27.0K<0.1%+3,485NewHolders